Breaking News

Church & Dwight Buys Del Labs for $380 Million

May 5, 2008

Church & Dwight Co., Inc. will acquire the Del Pharmaceuticals, Inc. business for $380 million in cash from Coty Inc. The transaction, which is subject to regulatory approval and other customary conditions, is expected to close in July.

Del Pharmaceuticals’ net sales in the fiscal year ended Dec. 31, 2007 were approximately $100 million. Over three quarters of those sales were from the Orajel brand, the No. 1 brand in the oral analgesic category, with remaining sales from a variety of other OTC brands.

Church & Dwight’s 2007 net sales of $2.2 billion include its premium oral care business led by the Arm & Hammer toothpaste and SpinBrush brands. According to the company, adding the Orajel brand will immediately increase the gross margin and will complement the strategy of building scale in core categories. The Orajel products are expected to be integrated into existing Church & Dwight manufacturing facilities by the end of 2009.
blog comments powered by Disqus
  • Free and Clear

    Free and Clear

    Melissa Meisel, Associate Editor||October 17, 2016
    OY-L aims for zero-chemical skin care.

  • Coming Clean on a Host of Issues

    October 17, 2016
    Cleaning Products Conference is set for Nov. 9-11, 2016 in Washington DC.

  • Let the Magic Begin!

    Let the Magic Begin!

    Tom Branna, Editorial Director||October 10, 2016
    IFSCC Congress gets underway at Walt Disney World this month.

  • Change Is in the Air

    Change Is in the Air

    Doreen Wang, BrandZ ||October 3, 2016
    Technology is changing the personal care market

  • Skin Care of One’s Own

    Skin Care of One’s Own

    Christine Esposito, Associate Editor||October 3, 2016
    Nu Skin’s ageLOC Me—which melds the worlds of smart-phone technology, efficacious ingredients and personalization

  • Proof Positive

    Proof Positive

    Christine Esposito, Associate Editor||October 3, 2016
    Testing service providers enable companies to back up their claims and stay in compliance with regulations.